News

Congratulations to Eric Mallack, M.D. and Weill Cornell Medicine collaborators on the approval of their upcoming international gene therapy trial entitled, “A Phase 1/2 Open-Label, Multicenter, Dose Ranging and Confirmatory Study to Assess the Safety, Tolerability and Efficacy of PBKR03 Administered to Pediatric Subjects with Early Infantile Krabbe Disease (Globoid Cell Leukodystrophy)."  Dr. Eric Mallack will serve as Primary Investigator of the study.

Infantile Krabbe disease, or globoid cell leukodystrophy, is a genetic disorder of the nervous system that usually results in death before the age of two. It is caused by mutations in the GALC gene which encodes an enzyme responsible for the breakdown of multiple lipids in the brain. In Krabbe disease, there is a toxic accumulation of these lipids in cells throughout the nervous system. This results in progressive neurodegeneration: brain atrophy, spasticity, loss of hearing and vision, seizures, weight loss, aspiration, loss of development milestones and early mortality.

Dr. Cori Green

We are pleased to announce that Cori Green, M.D., M.Sc. has been selected to serve on the 2022-2023 Best Children’s Hospital Behavioral/Mental Health working group, an initiative developed by the U.S. News & World Report (USNWR).

Dr. Green is the Director of Behavioral Health Education and Integration and Associate Professor of Clinical Pediatrics in the Department of Pediatrics at Weill Cornell Medicine. She was nominated by her colleagues at Weill Cornell Medicine and NewYork-Presbyterian Hospital for her ongoing contributions in changing care for patients and families, and improving the education programs for trainees and faculty at Weill Cornell Medicine.

Anita Mesi  

We are pleased to announce Anita Mesi, M.B.A. has been appointed as the new Chief Administrative Officer (CAO) for the Department of Pediatrics at Weill Cornell Medicine and NewYork-Presbyterian/Weill Cornell Medical Center. Ms. Mesi succeeds Gerald Boshi, who has retired, and whom we thank for his years of outstanding service, commitment, and excellence to the Department of Pediatrics.

Ms. Mesi received her Bachelor of Arts in Economics from Hunter College in 2004 and her Master of Business Administration in Finance and Investments and Organizational Behavior-Human Resource Management from the Zicklin School of Business, Baruch College in 2010. She joined Weill Cornell Medicine in 2002 as an intern while an undergraduate predental student at Hunter, but in turn, stayed and built her professional career as an academic administrator, holding several positions in the Departments of Biochemistry, Population Health Sciences (previously known as the Department of Public Health) and Medicine. 

The Weill Cornell Medicine Department of Pediatrics is pleased to announce the appointment of Jennifer I. DiPace, M.D. as Vice Chair of Education as of July 1, 2021. In this new role, Dr. DiPace will oversee the complex educational mission of the Department, including the coordination of faculty and trainees involved in that mission. We would like to thank Susan Bostwick, M.D., M.B.A. for her outstanding service as Executive Vice Chair of Education and Administration and are thrilled she will continue her leadership as Executive Vice Chair of Administration and Faculty.

A recognized and respected national leader in medical education, academic pediatrics and trainee/faculty mentorship, Dr. DiPace brings strong organizational skills and a commitment to collaboration and inclusion. As Vice Chair of Education, Dr. DiPace will lead the Department’s educational initiatives across the spectrum of activities related to undergraduate medical education (UME), graduate medical education (GME) at both residency and fellowship levels, and professional development such as continuing medical education (CME).